Desquilbet and Bullock (2010) criticize some aspects of our analysis of the European Union's (EU) spatial ex ante coexistence regulations (SEACERs) of genetically modified (GM) and non-GM crops presented in Demont et al. (2009). We argue that, besides misinterpreting some of our original...

Some argue that the lack of modern agricultural development in the former socialist countries of Central and Eastern Europe has made cutting-edge biotechnology attractive. However, enthusiasm for planting genetically modified (GM) crops varies greatly in the enlarged European Union (EU) and...

The EU is currently struggling to implement coherent coexistence regulations on genetically modified (GM) and non-GM crops in all member states. While it stresses that any approach needs to be “proportionate to the aim of achieving coexistence”, very few studies have actually attempted to...

Europe is currently struggling to implement coherent coexistence regulations on genetically modified (GM) and non-GM crops in all EU Member States. We conduct simulations with the software ArcView® on a GIS dataset of a hypothetical case of GM herbicide tolerant oilseed rape cultivation in...

<heading id="h1" level="1" implicit="yes" format="display">summary</heading><title type="document">GM Crops in Europe: How Much Value and for Whom?</title>Who gains from genetically modified (GM) crops in Europe? We review the global impact literature and assess the potential value of GM crops for Europe and how this value is shared among stakeholders. The literature suggests that, on average,...

Although the EU is still in a quasi moratorium stage concerning GM crops, doors for GM crops in the sugar industry seem to open. Herbicide tolerant sugar beet could mean a boost for the sugar beet sector. The ex ante impact assessment shows a created welfare of 15 billion during 1996-2014. The...

After more than a decade of GM crops, literature reports farmers and consumers can gain significantly from the technology, despite the intellectual property rights assigned to the innovator. In this paper we assess the effect of heterogeneity on this distribution of benefits. A two dimensional...

Since most of the recent agricultural biotechnology innovations have been developed by private companies, the central focus of societal interest is on the distribution of the gains from these technologies among all stakeholders. In a partial equilibrium model, assuming perfect corporate pricing...

"In July 2006, the European Union's (EU) Common Market Organization (CMO) for sugar underwent the first radical reform since its establishment in 1968. In this article, we study the incentives for adoption of new technologies before and after the policy reform. We build a stochastic partial...